1st Quarter - Report
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$23,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | May 18, 2012 | $23,000 | Replaced |
| 1st Quarter - Amendment | Oct 18, 2012 | $67,350 | Replaced |
| 1st Quarter - Amendment | Aug 6, 2013 | $67,350 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2013 NIH/NCI appropriations FY 2013 CDC appropriations FY 2013 DoD appropriations Prescription Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GEORGE DAHLMAN | — |
| LOUIS JAMES DEGENNARO | — |
| MARK VELLECA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.